Hefei Institutes of Physical Science; Chinese Academy of Sciences
发明人:
申请号：
EP18791988.1
公开号：
EP3636663A1
申请日:
2018.04.11
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present disclosure relates to a human FGF21 mutant, a preparation method and a use thereof, and specifically relates to a human fibroblast growth factor 21 (FGF21) mutant, a gene encoding the same, and a method for preparing the mutant and a method of using the mutant for treating type 2 diabetes, obesity, dyslipidemia, or metabolic disorders.
